Nigeria TV Info — Rahoton Labarai

A wani babban ci gaba wajen dakile yaduwar cutar HIV a duniya, Hukumar Lafiya ta Duniya (WHO) ta amince da amfani da lenacapavir (LEN) na allura a matsayin sabon zaɓin rigakafin HIV kafin kamuwa da ita (PrEP).

An sanar da wannan sabuwar shawarar yayin taron ƙungiyar AIDS ta duniya karo na 13 (IAS 2025) da aka gudanar a Kigali, Rwanda — wanda ke nuna wani muhimmin juyi a yaƙin da ake yi da cutar HIV.

A cewar WHO, lenacapavir — wanda ake yi wa mutum allura duk bayan watanni shida — ya nuna ƙarfin ƙwarai wajen hana kamuwa da cutar ga waɗanda ke cikin haɗarin kamuwa da HIV. Ana sa ran cewa wannan tsari na dogon lokaci zai taimaka wajen ƙara bin ka’ida fiye da magungunan kwayoyi na baki da ake sha kullum, wanda ya kasance ƙalubale a al’ummomi da dama.

Masana harkar kiwon lafiya sun yaba da wannan mataki, suna mai jaddada cewa yin allura sau biyu a shekara na iya taimakawa wajen cike gibi a bangaren rigakafin HIV, musamman a ƙasashe masu ƙaramin ko matsakaicin ƙarfin tattalin arziki. Haka kuma, WHO ta bukaci kasashen duniya da su sabunta shirye-shiryen rigakafin HIV na ƙasashensu domin haɗa LEN tare da tabbatar da cewa kowa zai iya samun damar amfani da shi.

Yayin bayani a taron, Darakta Janar na WHO, Dr. Tedros Adhanom Ghebreyesus, ya bayyana wannan shawarar a matsayin “muhimmin juyi” tare da kira ga gwamnatoci da abokan aikin kiwon lafiya da su gaggauta daukar matakai don samar da wannan sabuwar hanya ga jama'a.

Shigowar LEN wani bangare ne na kokarin da ake yi na kawo ƙarshen cutar AIDS a matsayin barazanar lafiyar jama’a nan da shekarar 2030. Hukumar lafiya ta duniya da sauran hukumomi sun ce haɗa sabbin fasahohi kamar lenacapavir da kuma ci gaba da samun damar gwaji da magani na da matuƙar muhimmanci wajen cimma wannan manufa.